highperformr logo

Curis's Overview

Total employees166
HeadquartersLexington
Founded2000

Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. The company's pipeline includes emavusertib (CA-4948), an IRAK4 kinase inhibitor, and fimepinostat (CI-8993), a dual inhibitor of PI3K and HDAC, targeting VISTA. Curis is dedicated to advancing novel drug candidates that have the potential to make a meaningful difference in the lives of patients with cancer.

Where is Curis's Headquarters?

HQ Function

The headquarters serves as the central hub for Curis's research and development operations, clinical development, corporate administration, and strategic planning.

Notable Features:

Modern office park setting optimized for biotech research and collaboration, providing advanced laboratory and office spaces.

Work Culture:

The work culture at Curis's headquarters is dynamic and science-driven, fostering innovation, collaboration, and a strong sense of purpose among its teams dedicated to oncology research. It reflects the fast-paced and mission-oriented environment typical of the biotech industry.

HQ Significance:

Its location in the Boston/Cambridge biotech cluster provides Curis with access to a rich ecosystem of talent, leading research institutions, and potential industry collaborators, which is crucial for a company focused on cutting-edge cancer therapeutics.

Values Reflected in HQ: The choice of a location within a premier biotech hub and a facility supporting advanced R&D reflects Curis's commitment to scientific excellence, innovation, and collaboration in its pursuit of transformative cancer therapies.

Location:

Curis, Inc. establishes its global presence primarily through its clinical development programs. The company conducts clinical trials for its oncology drug candidates in multiple countries, collaborating with research institutions and healthcare providers worldwide. This international approach is essential for gathering diverse patient data and advancing its therapies towards potential regulatory approval and commercialization in various markets.

Street Address:

128 Spring Street, Suite 500

City:

Lexington

State/Province:

MA

Country:

USA

Curis's Global Presence

Buying Intent Signals for Curis

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Curis

As of April 2025, Curis' leadership includes:

James Dentzer - President and Chief Executive Officer
Robert Martell, M.D., Ph.D. - Head of Research and Development
Diantha Duvall - Chief Financial Officer
William Steinkrauss - General Counsel and Chief Compliance Officer

Investors of Curis

Curis has been backed by several prominent investors over the years, including:

BlackRock Inc.
The Vanguard Group, Inc.
State Street Corporation
Geode Capital Management, LLC
FMR LLC (Fidelity Management & Research)

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

Curis experienced a key transition in its financial leadership over the past year, with the departure of its CFO in late 2023 and the subsequent appointment of a new CFO in early 2024.

Departures

Richard Muhammad, Richard Muhammad departed from his role as Chief Financial Officer.

New Appointments:

Diantha Duvall, Diantha Duvall appointed as new Chief Financial Officer.

Technology (Tech Stack) used by Curis

Discover the tools Curis uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Curis Email Formats and Examples

Curis, Inc. commonly utilizes an email format that combines the first initial of an employee's name with their last name, followed by the company domain '@curis.com'. This is a frequent pattern in many corporations.

[first_initial][last]@curis.com

Format

jdoe@curis.com

Example

80%

Success rate

News and media

GlobeNewswireMay 7, 2024

Curis Reports First Quarter 2024 Financial Results and Provides Corporate Update

Curis announced its financial results for Q1 2024, highlighting progress in its clinical programs for emavusertib and fimepinostat, and outlining its strategic priorities for advancing its oncology pipeline....more

GlobeNewswireFebruary 27, 2024

Curis Appoints Diantha Duvall as Chief Financial Officer

Curis announced the appointment of Diantha Duvall as its new CFO, bringing over 20 years of biopharmaceutical financial experience to the company, effective February 26, 2024....more

GlobeNewswireJanuary 4, 2024

Curis Provides Update on Phase 1/2 TakeAim Lymphoma Study of Emavusertib

Curis provided an update on its TakeAim Lymphoma study for emavusertib, detailing enrollment progress, initial clinical data, and strategic plans for the development in patients with B-cell malignancies....more

GlobeNewswireSeptember 26, 2023

Curis Announces CFO Transition

Curis announced that Richard Muhammad, Chief Financial Officer, would be leaving the Company, effective October 13, 2023, to pursue another opportunity. The company initiated a search for a new CFO....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Curis, are just a search away.